CA Stock MarketDetailed Quotes

LBL Lattice Biologics Ltd

Watchlist

0.000
0.0000.00%

15min DelayMarket Closed Jul 18 09:30 ET

0Market Cap0.00P/E (TTM)

Lattice Biologics Ltd Key Stats

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Jun 30, 2021

(Q2)Mar 31, 2021

(Q1)Dec 31, 2020

(FY)Sep 30, 2020

(Q4)Sep 30, 2020

(Q3)Jun 30, 2020

(Q2)Mar 31, 2020

(Q1)Dec 31, 2019

(FY)Sep 30, 2019

(Q4)Sep 30, 2019

Assets

Current assets

Cash, cash equivalents and short term investments

----

155.52%25.85K

30.10%24.19K

265.18%57.22K

231.22%19.65K

3,578.18%10.12K

863.97%18.6K

143.01%15.67K

-Cash and cash equivalents

----

155.52%25.85K

30.10%24.19K

265.18%57.22K

231.22%19.65K

3,578.18%10.12K

863.97%18.6K

143.01%15.67K

-Accounts receivable

----

--0

-58.87%178.17K

9.72%289.58K

9.45%358.29K

-55.56%211.99K

33.91%433.19K

54.03%263.93K

Total current assets

----

-97.33%25.85K

-21.62%816.32K

-13.15%901.63K

-37.69%1.02M

-48.66%968.21K

-40.53%1.04M

-38.12%1.04M

Non current assets

-Accumulated depreciation

----

-82.95%-637.03K

-41.40%-467.75K

-21.63%-381.24K

-23.03%-364.32K

-24.03%-348.2K

-24.66%-330.79K

-Long term equity investment

----

--0

163.31%845.87K

338.11%887.71K

-25.19%555.74K

-58.75%299.38K

-77.27%321.24K

-71.65%202.62K

-Goodwill

-8.70%606.43K

-10.26%606.43K

-14.64%606.43K

-18.61%606.43K

-14.82%664.21K

-17.03%675.76K

-16.33%710.43K

-15.69%745.09K

-Other intangible assets

-95.58%21.86K

0.00%494.15K

0.27%494.15K

1.24%494.15K

--494.15K

4.44%494.15K

Regulatory assets

----

--0

-58.87%178.17K

9.72%289.58K

9.45%358.29K

-55.56%211.99K

33.91%433.19K

54.03%263.93K

Liabilities

Current liabilities

Current debt and capital lease obligation

----

16.55%2.44M

16.54%2.25M

82.39%2.45M

83.79%2.43M

56.02%2.09M

47.14%1.93M

-Current debt

----

16.41%2.28M

10.45%2.09M

76.12%2.3M

78.98%2.29M

50.31%1.96M

48.13%1.89M

-Current capital lease obligation

----

--0

18.50%162.2K

324.25%158.7K

278.35%157.86K

232.63%137.6K

241.28%136.88K

9.88%37.41K

-accounts payable

-82.14%505.69K

-42.88%1.53M

16.41%3.47M

11.45%3.56M

-0.78%2.83M

-5.52%2.67M

3.41%2.98M

9.03%3.19M

-Total tax payable

--0

-29.96%700K

51.37%1.55M

75.90%1.59M

-12.97%1.26M

-29.90%999.38K

-27.75%1.02M

-36.20%902.62K

Current accrued expenses

----

-28.44%1.66M

-27.08%1.65M

-12.32%2.24M

3.16%2.65M

-5.00%2.32M

-1.07%2.27M

Current provisions

----

-30.57%256.79K

10.00%250.53K

7.53%369.83K

3.46%369.83K

-1.52%369.83K

-38.50%227.75K

Current deferred liabilities

----

--0

Current liabilities

-93.72%505.69K

-82.20%1.53M

2.01%7.99M

1.91%7.83M

12.86%8.05M

19.76%8.57M

10.28%7.84M

10.20%7.68M

Non current liabilities

-Long term debt

----

--0

272.56%512.64K

123,430.16%544.77K

12,503.65%214.01K

3,964.48%116.24K

1,641.97%137.6K

-96.99%441

Non current accrued expenses

----

--0

100.11%1.45M

207.22%1.51M

55.56%793.97K

32.00%692.02K

47.59%722.65K

-2.67%491.54K

Long term provisions

----

81.45%333.22K

69.62%342.94K

-53.89%341.73K

-74.67%183.13K

-86.93%183.65K

-71.12%202.18K

Total non current liabilities

-94.57%505.69K

-76.75%2.23M

7.70%9.54M

9.69%9.42M

8.51%9.3M

11.51%9.57M

3.97%8.86M

2.38%8.59M

Shareholders'equity

Share capital

6.41%11.01M

14.49%11.01M

7.59%10.35M

0.00%9.62M

--9.62M

0.00%9.62M

-common stock

6.41%11.01M

14.49%11.01M

7.59%10.35M

0.00%9.62M

--9.62M

0.00%9.62M

Total equity

-75.54%606.43K

-72.93%632.27K

15.93%2.87M

32.68%3.02M

-15.34%2.48M

-27.56%2.34M

-19.92%2.47M

-25.81%2.27M

	(Q3)Jun 30, 2021	(Q2)Mar 31, 2021	(Q1)Dec 31, 2020	(FY)Sep 30, 2020	(Q4)Sep 30, 2020	(Q3)Jun 30, 2020	(Q2)Mar 31, 2020	(Q1)Dec 31, 2019	(FY)Sep 30, 2019	(Q4)Sep 30, 2019
Assets
Current assets
Cash, cash equivalents and short term investments	----	155.52%25.85K	30.10%24.19K	265.18%57.22K	265.18%57.22K	231.22%19.65K	3,578.18%10.12K	863.97%18.6K	143.01%15.67K	143.01%15.67K
-Cash and cash equivalents	----	155.52%25.85K	30.10%24.19K	265.18%57.22K	265.18%57.22K	231.22%19.65K	3,578.18%10.12K	863.97%18.6K	143.01%15.67K	143.01%15.67K
-Accounts receivable	----	--0	-58.87%178.17K	9.72%289.58K	9.72%289.58K	9.45%358.29K	-55.56%211.99K	33.91%433.19K	54.03%263.93K	54.03%263.93K
Total current assets	----	-97.33%25.85K	-21.62%816.32K	-13.15%901.63K	-13.15%901.63K	-37.69%1.02M	-48.66%968.21K	-40.53%1.04M	-38.12%1.04M	-38.12%1.04M
Non current assets
-Accumulated depreciation	----	----	-82.95%-637.03K	-41.40%-467.75K	-41.40%-467.75K	-21.63%-381.24K	-23.03%-364.32K	-24.03%-348.2K	-24.66%-330.79K	-24.66%-330.79K
-Long term equity investment	----	--0	163.31%845.87K	338.11%887.71K	338.11%887.71K	-25.19%555.74K	-58.75%299.38K	-77.27%321.24K	-71.65%202.62K	-71.65%202.62K
-Goodwill	-8.70%606.43K	-10.26%606.43K	-14.64%606.43K	-18.61%606.43K	-18.61%606.43K	-14.82%664.21K	-17.03%675.76K	-16.33%710.43K	-15.69%745.09K	-15.69%745.09K
-Other intangible assets	-95.58%21.86K	-95.58%21.86K	0.00%494.15K	0.00%494.15K	0.00%494.15K	0.27%494.15K	1.24%494.15K	--494.15K	4.44%494.15K	4.44%494.15K
Regulatory assets	----	--0	-58.87%178.17K	9.72%289.58K	9.72%289.58K	9.45%358.29K	-55.56%211.99K	33.91%433.19K	54.03%263.93K	54.03%263.93K
Liabilities
Current liabilities
Current debt and capital lease obligation	----	----	16.55%2.44M	16.54%2.25M	16.54%2.25M	82.39%2.45M	83.79%2.43M	56.02%2.09M	47.14%1.93M	47.14%1.93M
-Current debt	----	----	16.41%2.28M	10.45%2.09M	10.45%2.09M	76.12%2.3M	78.98%2.29M	50.31%1.96M	48.13%1.89M	48.13%1.89M
-Current capital lease obligation	----	--0	18.50%162.2K	324.25%158.7K	324.25%158.7K	278.35%157.86K	232.63%137.6K	241.28%136.88K	9.88%37.41K	9.88%37.41K
-accounts payable	-82.14%505.69K	-42.88%1.53M	16.41%3.47M	11.45%3.56M	11.45%3.56M	-0.78%2.83M	-5.52%2.67M	3.41%2.98M	9.03%3.19M	9.03%3.19M
-Total tax payable	--0	-29.96%700K	51.37%1.55M	75.90%1.59M	75.90%1.59M	-12.97%1.26M	-29.90%999.38K	-27.75%1.02M	-36.20%902.62K	-36.20%902.62K
Current accrued expenses	----	----	-28.44%1.66M	-27.08%1.65M	-27.08%1.65M	-12.32%2.24M	3.16%2.65M	-5.00%2.32M	-1.07%2.27M	-1.07%2.27M
Current provisions	----	----	-30.57%256.79K	10.00%250.53K	10.00%250.53K	7.53%369.83K	3.46%369.83K	-1.52%369.83K	-38.50%227.75K	-38.50%227.75K
Current deferred liabilities	----	----	----	----	----	----	----	----	--0	--0
Current liabilities	-93.72%505.69K	-82.20%1.53M	2.01%7.99M	1.91%7.83M	1.91%7.83M	12.86%8.05M	19.76%8.57M	10.28%7.84M	10.20%7.68M	10.20%7.68M
Non current liabilities
-Long term debt	----	--0	272.56%512.64K	123,430.16%544.77K	123,430.16%544.77K	12,503.65%214.01K	3,964.48%116.24K	1,641.97%137.6K	-96.99%441	-96.99%441
Non current accrued expenses	----	--0	100.11%1.45M	207.22%1.51M	207.22%1.51M	55.56%793.97K	32.00%692.02K	47.59%722.65K	-2.67%491.54K	-2.67%491.54K
Long term provisions	----	----	81.45%333.22K	69.62%342.94K	69.62%342.94K	-53.89%341.73K	-74.67%183.13K	-86.93%183.65K	-71.12%202.18K	-71.12%202.18K
Total non current liabilities	-94.57%505.69K	-76.75%2.23M	7.70%9.54M	9.69%9.42M	9.69%9.42M	8.51%9.3M	11.51%9.57M	3.97%8.86M	2.38%8.59M	2.38%8.59M
Shareholders'equity
Share capital	6.41%11.01M	14.49%11.01M	14.49%11.01M	14.49%11.01M	14.49%11.01M	7.59%10.35M	0.00%9.62M	--9.62M	0.00%9.62M	0.00%9.62M
-common stock	6.41%11.01M	14.49%11.01M	14.49%11.01M	14.49%11.01M	14.49%11.01M	7.59%10.35M	0.00%9.62M	--9.62M	0.00%9.62M	0.00%9.62M
Total equity	-75.54%606.43K	-72.93%632.27K	15.93%2.87M	32.68%3.02M	32.68%3.02M	-15.34%2.48M	-27.56%2.34M	-19.92%2.47M	-25.81%2.27M	-25.81%2.27M

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List

Overall

LBL Lattice Biologics Ltd

Lattice Biologics Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow